Companies

Novo Nordisk and the diabetes epidemic

Name: Novo Nordisk and the diabetes epidemic
Uploaded: 2014-09-10T10:28:22.729Z
Duration: 6 min 3 s
Channel: Financial Times
Description: Rising insulin sales boost growth at Danish pharma group

Rising insulin sales have made Novo Nordisk one of the strongest growth stories in the pharma sector. FT pharmaceuticals correspondent Andrew Ward asks chief executive Lars Sørensen if the company prefers treating the disease rather than finding a cure.

September 10, 2014

Produced by Nalini Sivathasan. Filmed by Nicola Stansfield and Petros Gioumpasis. Additional footage from Novo Nordisk.